FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study).
Cancer Diagn Progn. 2022 Jan 3;2(1):101-106. doi: 10.21873/cdp.10083. eCollection 2022 Jan-Feb.
Cancer Diagn Progn. 2022.
PMID: 35400007
Free PMC article.